Volume 10 Supplement 1
2nd Cross Company Respiratory Symposium
Meeting abstracts
Edited by Richard Knowles and Kathy H Abbott-Banner
The conference and publication of this supplement were supported by Pfizer. The organizing committee, which included a representative from Pfizer, was involved in selecting abstracts for oral and poster presentations at the meeting. RK is a scientific consultant on respiratory and inflammation models on drug discovery as well as CEO of an SME developing anti-inflammatory medicines. KAB has no competing interests.
2nd Cross Company Respiratory Symposium.
Horsham, UK6-7 September 2012
-
Citation: Journal of Inflammation 2013 10(Suppl 1):I1
-
Assessment of the time course of chronic inflammation in the murine house dust mite model
Citation: Journal of Inflammation 2013 10(Suppl 1):P1 -
In-depth assessment of acute and chronic house dust mite-induced asthma mouse models
Citation: Journal of Inflammation 2013 10(Suppl 1):P2 -
Modulation of IL-17A and TL1A largely abrogates house dust mite-induced lung inflammation in murine model of allergic airway disease
Citation: Journal of Inflammation 2013 10(Suppl 1):P3 -
Longitudinal characterisation of a model of chronic allergic lung inflammation in mice using imaging, functional and immunological methods
Citation: Journal of Inflammation 2013 10(Suppl 1):P4 -
Acidic mammalian chitinase is not a critical target for allergic airway disease in mice
Citation: Journal of Inflammation 2013 10(Suppl 1):P5 -
Characterisation of the allergic phenotype resulting from a shortened HDM challenge protocol in mice
Citation: Journal of Inflammation 2013 10(Suppl 1):P6 -
Immunological characterisation of an acute murine model of lung inflammation and airway hyperreactivity
Citation: Journal of Inflammation 2013 10(Suppl 1):P7 -
Alterations in airway mechanics, inflammatory biomarkers and lung histopathology in a rat model of allergen-induced airway inflammation
Citation: Journal of Inflammation 2013 10(Suppl 1):P8 -
Brown Norway ovalbumin model: temporal profile of cytokines
Citation: Journal of Inflammation 2013 10(Suppl 1):P9 -
Alternaria alternata induced inflammatory lung responses: a novel in vivo PK/PD model
Citation: Journal of Inflammation 2013 10(Suppl 1):P10 -
Exploring the role of SYK in respiratory in vivo models
Citation: Journal of Inflammation 2013 10(Suppl 1):P11 -
Time-course of inflammation and allergic bronchoconstrictor response in a model of ovalbumin-induced rapid pulmonary inflammation in Brown Norway rats
Citation: Journal of Inflammation 2013 10(Suppl 1):P12 -
Effect of the circadian cycle in Late Asthmatic Response (LAR). Comparison between two allergic asthma models in rats and mice
Citation: Journal of Inflammation 2013 10(Suppl 1):P13 -
A novel TLR-8 agonist attenuates nasal symptoms/congestion in both dog and human allergen challenge studies
Citation: Journal of Inflammation 2013 10(Suppl 1):P14 -
Assessment of multiple pharmacological mechanisms in the ascaris sensitive sheep model of allergic asthma
Citation: Journal of Inflammation 2013 10(Suppl 1):P15 -
Development of a model of Ascaris Suum antigen-induced pulmonary inflammation in nonhuman primates
Citation: Journal of Inflammation 2013 10(Suppl 1):P16 -
Plasmacytoid dendritic cells downregulate the allergen induced T cell proliferation in a human in vitro allergy model
Citation: Journal of Inflammation 2013 10(Suppl 1):P17 -
Mast cell mediators cause the early allergic bronchoconstriction in guinea pigs in vivo: a model of relevance to asthma
Citation: Journal of Inflammation 2013 10(Suppl 1):P18 -
Strategies to mimic virally induced asthmatic exacerbations: the use of rhinovirus and influenza in acute and chronic mouse models
Citation: Journal of Inflammation 2013 10(Suppl 1):P19 -
Impaired anti-viral immune response to human rhinovirus 1B infection in chronic allergic airway inflammation does not manifest in asthma exacerbation
Citation: Journal of Inflammation 2013 10(Suppl 1):P20 -
Poly I:C causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund's complete adjuvant
Citation: Journal of Inflammation 2013 10(Suppl 1):P21 -
Mouse model of HDM induced airway inflammation + influenza or RSV. Effects of steroid
Citation: Journal of Inflammation 2013 10(Suppl 1):P22 -
Influenza exacerbations in an acute and chronic house dust mite ‘asthma’ model
Citation: Journal of Inflammation 2013 10(Suppl 1):P23 -
Antiviral effect of eosinophils in respiratory tract infection with influenza virus in mice
Citation: Journal of Inflammation 2013 10(Suppl 1):P24 -
Preclinical animal models of COPD
Citation: Journal of Inflammation 2013 10(Suppl 1):P25 -
Characterization of MMP-9 and -12 KO mice in a model of acute smoke exposure
Citation: Journal of Inflammation 2013 10(Suppl 1):P26 -
Relative sensitivity of mice to inhaled ozone and cigarette smoke exposure
Citation: Journal of Inflammation 2013 10(Suppl 1):P27 -
A translational approach to test anti-inflammatory drugs in a LPS induced acute lung inflammation model in the common marmoset (Callithrix jacchus)
Citation: Journal of Inflammation 2013 10(Suppl 1):P28 -
Lipopolysaccharide (LPS) segmental lung challenge in nonhuman primates – a model of airway inflammation
Citation: Journal of Inflammation 2013 10(Suppl 1):P29 -
Steroid insensitive respiratory inflammation - an acute tobacco smoke model
Citation: Journal of Inflammation 2013 10(Suppl 1):P30 -
Steroid-insensitive tobacco smoke-induced lung inflammation models in the mouse
Citation: Journal of Inflammation 2013 10(Suppl 1):P31 -
A mouse model of acute exacerbations of lung inflammation in COPD with both steroid-sensitive and steroid-insensitive features
Citation: Journal of Inflammation 2013 10(Suppl 1):P32 -
Interleukin-6 neutralization alleviates acute exacerbation-like disease in a model of cigarette smoke-induced pulmonary inflammation
Citation: Journal of Inflammation 2013 10(Suppl 1):P33 -
A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C
Citation: Journal of Inflammation 2013 10(Suppl 1):P34 -
Strategies to improve lung absorption of intratracheally administered compounds in Drug Discovery
Citation: Journal of Inflammation 2013 10(Suppl 1):P35 -
Dry powder inhaled compound delivery for early pre-clinical in vivo efficacy studies
Citation: Journal of Inflammation 2013 10(Suppl 1):P36 -
Effects of Multikinase inhibitors on pressure overload-induced right ventricular remodelling
Citation: Journal of Inflammation 2013 10(Suppl 1):P37 -
Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis
Citation: Journal of Inflammation 2013 10(Suppl 1):P38 -
Considerations for therapeutic intervention models of pulmonary fibrosis
Citation: Journal of Inflammation 2013 10(Suppl 1):P39 -
Do allergic dogs exhibit features of a severe steroid-resistant allergic airway phenotype?
Citation: Journal of Inflammation 2013 10(Suppl 1):P40 -
Viral exacerbation of chronic airway inflammation in BALB/c mice sensitized with house dust mite (HDM): a role for corticosteroids?
Citation: Journal of Inflammation 2013 10(Suppl 1):P41
Affiliated with the British Inflammation Research Association (BIRAs).
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.6
Source Normalized Impact per Paper (SNIP): 0.770
SCImago Journal Rank (SJR): 0.932Speed 2023
Submission to first editorial decision (median days): 14
Submission to acceptance (median days): 113Usage 2023
Downloads: 462,203
Altmetric mentions: 675